Last March, during the early days of the COVID-19 pandemic, Medicare temporarily eased the telemedicine requirements for reimbursement in order to increase access to care and reserve in-office visits for the sickest patients; in this way, Americans have been able to reduce exposure to COVID-19, for both themselves and healthcare workers, while continuing to receive needed care. However, the unprecedented rapid growth of telemedicine has been accompanied by a rise in telemedicine fraud cases and abuses. Whatever the error may be, the Department of Justice (DOJ) has begun holding offenders accountable for their actions. Ultimately, the telemedicine industry and healthcare providers will find themselves under closer scrutiny in the future. Read more